{
    "clinical_study": {
        "@rank": "166580", 
        "arm_group": [
            {
                "arm_group_label": "HFT group", 
                "arm_group_type": "Experimental", 
                "description": "Subjects in the High Frequency Therapy (HFT) group will be treated with the BTL-9000 HFT"
            }, 
            {
                "arm_group_label": "Placebo group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Subjects in the Placebo group with be treated with the sham BTL-9000 HFT"
            }
        ], 
        "brief_summary": {
            "textblock": "Prospective, two-arm, randomized study of the effectiveness of the BTL-9000 HFT in achieving\n      3 cm or greater average waist circumferential reduction in HFT group of subjects relative to\n      the base line and 1 cm or greater reduction relative to the average waist circumferential\n      reduction of the Placebo group."
        }, 
        "brief_title": "BTL-9000 High Frequency Therapy for the Waist Circumferential Reduction", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Circumferential Reduction", 
            "Waist Circumferential Reduction"
        ], 
        "detailed_description": {
            "textblock": "Prospective, randomized, blinded, two-arms study of waist circumferential reduction\n      following 5 once-a-week treatments. One arm is the HFT group of 64 subjects who are treated\n      with the BTL-9000 HFT and the other arm is the Placebo group of 38 subjects treated with the\n      sham device.  The objective of the study is to demonstrate the effectiveness of the BTL-9000\n      HFT treatment in achieving average post-treatment waist circumference reduction of 3 cm or\n      greater across the waistline relative to the baseline assessment and of 1 cm or greater than\n      the average waist circumferential reduction of the Placebo group."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects 18-70 years of age of both gender with excess adipose tissue in the abdomen\n             area\n\n          -  Body Mass Index (BMI) of 25 to 35 kg/m2.\n\n          -  Subjects willing and able to abstain from partaking in any treatments other than the\n             study procedure to promote body contouring and/or weight loss during study\n             participation.\n\n          -  Subjects willing and able to maintain his/her regular (pre-procedure) diet and\n             exercise regimen without effecting significant change in either direction during\n             study participation.\n\n        Exclusion Criteria:\n\n          -  - Diabetics dependent on insulin or oral hypoglycemic medications\n\n          -  Known cardiovascular disease such as arrhythmias, congestive heart failure\n\n          -  Cardiac surgeries such as cardiac bypass, heart transplant surgery, pacemakers.\n\n          -  Implanted electronic device such as a cardiac pacemaker, bladder stimulator, spinal\n             cord stimulator or electrodes for a myoelectric prosthesis, etc.\n\n          -  Prior surgical interventions for body sculpting of abdomen such as liposuction\n\n          -  Medical, physical or other contraindications for body sculpting/ weight loss\n\n          -  Current use of medication known to affect weight levels and/or cause bloating or\n             swelling and for which abstinence during the course of study participation is not\n             safe or medically prudent\n\n          -  Any medical condition known to affect weight levels and/or to cause bloating or\n             swelling\n\n          -  Active infection, wound or other external trauma to the area to be treated\n\n          -  Pregnant, breast feeding, or planning pregnant before the end of the study\n\n          -  Serious mental health illness\n\n          -  Negative affection to heat\n\n          -  Active or recurrent cancer or current chemotherapy and/or radiation treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "102", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02023398", 
            "org_study_id": "BTL-9000 HFT"
        }, 
        "intervention": [
            {
                "arm_group_label": "HFT group", 
                "description": "Deep tissue heating with the BTL-9000 HFT for HFT group", 
                "intervention_name": "BTL-9000 HFT", 
                "intervention_type": "Device", 
                "other_name": "BTL-9000 High Frequency Therapy"
            }, 
            {
                "arm_group_label": "Placebo group", 
                "description": "sham deep tissue heating with BTL-9000 HFT in Placebo group", 
                "intervention_name": "sham BTL-9000 HFT", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "High Frequency", 
            "Waist circumferential reduction"
        ], 
        "lastchanged_date": "December 26, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bratislava", 
                    "country": "Slovakia"
                }, 
                "name": "Polyklinika Mytna"
            }
        }, 
        "location_countries": {
            "country": "Slovakia"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of the Effectiveness of the BTL-9000 High Frequency Therapy for the Waist Circumferential Reduction", 
        "overall_official": {
            "affiliation": "Polyklinaka Mytna", 
            "last_name": "Iveta Hasova, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Slovakia: State Institute for Drug Control", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The subjects in the HFT group whose average post-treatment waist circumference shows reduction of 3 cm or greater across the waistline relative to the base line assessment and their mean waist circumferential reduction is 1 cm or greater than the average circumferential reduction of Placebo group are considered to meet the study primary outcome success criteria.", 
            "measure": "Waist Circumference Reduction", 
            "safety_issue": "No", 
            "time_frame": "1 month follow up after 5 once-a-week treatments"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02023398"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Absence of adverse events (AE) associated with the treatment procedure.  Safety evaluations of skin reaction in the treatment area would be conducted at every treatment and follow up visits", 
            "measure": "Adverse Events", 
            "safety_issue": "Yes", 
            "time_frame": "6 month follow up"
        }, 
        "source": "BTL Industries Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "BTL Industries Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}